Everyday Health on MSN1d
New UTI Antibiotic Is the First Approved by the FDA in Nearly 30 Years
Key TakeawaysBlujepa (gepotidacin) is the first new antibiotic class approved in nearly 30 years, providing a crucial ...
Medindia10d
Clostridioides Difficile Infection: Evolving Therapies from Antibiotics to AI
Clostridioides difficile infection is a major healthcare-associated infection, causing significant morbidity and mortality, ...
EurekAlert!15d
Clostridioides difficile infection: a review of emerging practices for infection treatment and prevention of recurrence
Clostridioides difficile (C. difficile) infection (CDI) is a significant healthcare-associated infection, known for its high morbidity and mortality rates, especially in vulnerable populations. CDI ...
The Hospitalist25d
Gram-Negative Bacteremia: Early Transition from IV to PO Antibiotic Therapy
Clinical question: What is the safety and efficacy of switching from IV to oral antibiotic therapy after three to five days in patients with gram-negative bacteremia? Background: Bacteremia is ...
BMJ25d
Evaluating an admission avoidance pathway for children in the emergency department: outpatient intravenous antibiotics for moderate/severe cellulitis
rch.org.au Objective Children with moderate/severe cellulitis requiring intravenous antibiotics are usually admitted to hospital. Admission avoidance is attractive but there are few data in children.
Newswire25d
Acurx Announces Publication of Nonclinical In Vivo Data Differentiating Ibezapolstat's Gut Microbiome Effects from Other Anti-CDI Antibiotics
difficile directed antibiotics, especially fidaxomicin. Although both ibezapolstat and fidaxomicin were narrower spectrum than vancomycin or metronidazole, ibezapolstat's effect on the microbiome ...
Medscape27d
Preventing Nosocomial Spread of MRSA is in Your Hands
Vancomycin may be inactivated if heparin is administered through the same intravenous line (Haddadin et al., 2002). Another glycopeptide antibiotic, teicoplanin (Targocid ®), is available and ...